These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21204744)

  • 1. Targeting diseases with genetically engineered Lactococcus lactis and its course towards medical translation.
    Villatoro-Hernandez J; Montes-de-Oca-Luna R; Kuipers OP
    Expert Opin Biol Ther; 2011 Mar; 11(3):261-7. PubMed ID: 21204744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterologous protein production and delivery systems for Lactococcus lactis.
    Nouaille S; Ribeiro LA; Miyoshi A; Pontes D; Le Loir Y; Oliveira SC; Langella P; Azevedo V
    Genet Mol Res; 2003 Mar; 2(1):102-11. PubMed ID: 12917806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress on lactococcus lactis expressing heterologous antigens as live mucosal vaccines].
    Shi D; Song Y; Li YJ
    Wei Sheng Wu Xue Bao; 2006 Aug; 46(4):680-3. PubMed ID: 17037080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactococcus lactis: from the dairy industry to antigen and therapeutic protein delivery.
    Bahey-El-Din M; Gahan CG
    Discov Med; 2010 May; 9(48):455-61. PubMed ID: 20515614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
    Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
    Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
    Hanniffy SB; Carter AT; Hitchin E; Wells JM
    J Infect Dis; 2007 Jan; 195(2):185-93. PubMed ID: 17191163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actobiotics as a novel method for cytokine delivery.
    Steidler L; Rottiers P; Coulie B
    Ann N Y Acad Sci; 2009 Dec; 1182():135-45. PubMed ID: 20074282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis.
    Villena J; Medina M; Racedo S; Alvarez S
    J Microbiol Immunol Infect; 2010 Feb; 43(1):1-10. PubMed ID: 20434117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10.
    Steidler L; Neirynck S; Huyghebaert N; Snoeck V; Vermeire A; Goddeeris B; Cox E; Remon JP; Remaut E
    Nat Biotechnol; 2003 Jul; 21(7):785-9. PubMed ID: 12808464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of lactococcal GEM-based pneumococcal vaccines.
    Audouy SA; van Selm S; van Roosmalen ML; Post E; Kanninga R; Neef J; Estevão S; Nieuwenhuis EE; Adrian PV; Leenhouts K; Hermans PW
    Vaccine; 2007 Mar; 25(13):2497-506. PubMed ID: 17081660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of biological active murine IFN-gamma by recombinant Lactococcus lactis.
    Bermúdez-Humarán LG; Cortes-Perez NG; L'Haridon R; Langella P
    FEMS Microbiol Lett; 2008 Mar; 280(2):144-9. PubMed ID: 18248432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a recombinant ureolytic Lactococcus lactis for urea removal.
    Zhang S; Li D; Tian K; Bai Y; Zhang H; Song C; Qiao M; Kong D; Yu Y
    Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(6):227-34. PubMed ID: 19900066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactococcus lactis as a cell factory for delivery of therapeutic proteins.
    Bahey-El-Din M; Gahan CG; Griffin BT
    Curr Gene Ther; 2010 Feb; 10(1):34-45. PubMed ID: 20156189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoprotection against influenza H5N1 virus by oral administration of enteric-coated recombinant Lactococcus lactis mini-capsules.
    Lei H; Xu Y; Chen J; Wei X; Lam DM
    Virology; 2010 Nov; 407(2):319-24. PubMed ID: 20850860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection.
    Villena J; Medina M; Raya R; Alvarez S
    Can J Microbiol; 2008 Oct; 54(10):845-53. PubMed ID: 18923553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface display system for Lactococcus lactis: a novel development for oral vaccine.
    Raha AR; Varma NR; Yusoff K; Ross E; Foo HL
    Appl Microbiol Biotechnol; 2005 Jul; 68(1):75-81. PubMed ID: 15635459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.
    Martín R; Chain F; Miquel S; Natividad JM; Sokol H; Verdu EF; Langella P; Bermúdez-Humarán LG
    Hum Vaccin Immunother; 2014; 10(6):1611-21. PubMed ID: 24732667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intranasal administration of Lactococcus lactis strains expressing recombinant interleukin-10 modulates acute allergic airway inflammation in a murine model.
    Marinho FA; Pacífico LG; Miyoshi A; Azevedo V; Le Loir Y; Guimarães VD; Langella P; Cassali GD; Fonseca CT; Oliveira SC
    Clin Exp Allergy; 2010 Oct; 40(10):1541-51. PubMed ID: 20412136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous protein expression by Lactococcus lactis.
    Villatoro-Hernández J; Kuipers OP; Saucedo-Cárdenas O; Montes-de-Oca-Luna R
    Methods Mol Biol; 2012; 824():155-65. PubMed ID: 22160898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactococcus lactis-based vaccines from laboratory bench to human use: an overview.
    Bahey-El-Din M
    Vaccine; 2012 Jan; 30(4):685-90. PubMed ID: 22154771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.